Parth Thakker, MD Profile
Parth Thakker, MD

@ThakkerP_UroMD

Followers
80
Following
49
Media
0
Statuses
12

@UroOnc fellow at at @IUuro by way of @wakeurology. Proud grad of @UofSC SOM and @FurmanU. Wayfarer, amateur cook, and tennis player.

Indianapolis, IN
Joined October 2022
Don't wanna be here? Send us removal request.
@UTCurology
UT-Chattanooga Urology
2 months
This August marks Dr. Taylor Peak’s first full year on our faculty. Over the past year, he’s given our residents excellent exposure to the retroperitoneum while providing expert care in urologic cancers, especially advanced testicular cancer.
1
1
24
@IU_UroOnc
IU_UroOnc
6 months
Congratulations to our PGY 2 Connor Drake and @UroOnc fellows, @ThakkerP_UroMD & @urozeng with the mentorship of Tim Masterson and @ClintCaryMD. Best poster award was given for their work regarding the utility of ctDNA in testicular germ cell tumor. @IUCancerCenter @IUuro
0
3
21
@IU_UroOnc
IU_UroOnc
8 months
Treating metastatic seminoma? Considering offering primary RPLND for early CS2 disease? Learn about the dissemination pattern of the disease and if a modified template is appropriate for these patients. @JUrology @urozeng @ClintCaryMD
0
6
20
@IU_UroOnc
IU_UroOnc
8 months
This year, we welcomed @JMHolzbeierlein for our Donohue visiting professorship. Great lectures on NMIBC, leadership, nephrectomy in silverback gorillas, and case presentations by residents of @IUuro. Thanks to @ClintCaryMD and Tim Masterson for organizing. @IUCancerCenter @UroOnc
0
3
12
@ClintCaryMD
Clint Cary, MD MPH MBA
8 months
Very proud of our 1st and 2nd year urologic oncology fellows @urozeng and Parth Thakker @ GU ASCO ‘25 presenting our work @IUuro @IUCancerCenter on ctDNA in GCTs and stage II Embryonal predominant GCT outcomes RPLND vs. chemotherapy
2
4
31
@IU_UroOnc
IU_UroOnc
8 months
Our fellows regularly present abstracts at @ASCO and at @AmerUrological. This year, both @urozeng and @ThakkerP_UroMD presented on the outcomes of stage 2 EC predominant undergoing RPLND vs chemotherapy & the role of ctDNA in GCT under Timothy Masterson and @ClintCaryMD.
1
5
20
@IU_UroOnc
IU_UroOnc
8 months
Our world class medical oncologists presenting on the intricacies of advanced testis cancer and the use of high dose chemotherapy at @ASCO. @nabiladra and Lawrence Einhorn in the front row. @IUCancerCenter @IUuro #GU
0
2
13
@RamPathakMD
Ram Pathak, M.D.
2 years
Great collaboration and work by @ThakkerP_UroMD and @wakeurology and @TimLyonMD @Laura_Geldmaker
@JEndourology
Journal of Endourology
2 years
Are there racial differences in pelvic dimensions, and how does this affect robotic prostatectomy? Several pelvis dimensions were found to be shorter/narrower in African Americans and were associated with longer operative times @RamPathakMD @MayoUrology https://t.co/baDCMeRdoM
0
2
9
@ARRODRIGUEZMD
Alejandro Rodriguez, MD, FACS
2 years
Thank you to the Argentine Society of Urology @SauUrologia and President Miguel Ángel Costa for this recognition! I am humbled to receive The Federico Texo Medal from the SAU, during the SAU Congress 2023. The 100 years event! @CAU_URO @ResidentesCAU @wakeurology
1
4
25
@ndeebel_uroMD
Nick Deebel, MD
2 years
Honored and thankful to receive the @ReprodMed_SMRU @SSMR_malefactor Traveling Scholar Award to the #ASRM2023 meeting! Excited to present all of our research from the past year. Special thanks to @jtheowhite and @ranjithramamd @dsui_miami_uro for their support and mentorship!
4
6
32
@IUuro
Indiana University Department of Urology
2 years
We are excited to have you here @ThakkerP_UroMD!
@ndeebel_uroMD
Nick Deebel, MD
2 years
Proud of my soon to be co-chief and friend @ThakkerP_UroMD for his @AmerUrological @UroOnc match at @lUuro! I cannot wait to see all that you accomplish in your two years at Indiana!
0
1
13
@ThakkerP_UroMD
Parth Thakker, MD
3 years
Our experience at Wake Forest Urology with "single-docking" robotic nephroureterectomy is feasible with good short-term outcomes. Check out our narrative review here! #UTUC #BeyondTheAbstract #RoboticSurgery @urologynephrol1 @UroOnc @urotoday https://t.co/4qOuv7zJ2A
0
1
3